A detailed history of Horizon Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Horizon Investments, LLC holds 44 shares of NVS stock, worth $4,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 40 10.0%
Holding current value
$4,864
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $370 - $429
4 Added 10.0%
44 $4,000
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $2,000 - $2,277
21 Added 110.53%
40 $3,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $1,753 - $1,929
19 New
19 $1,000
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $5.43 Million - $6.02 Million
-66,138 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $1.68 Million - $1.89 Million
20,785 Added 45.83%
66,138 $5.78 Million
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $3.21 Million - $4.49 Million
45,353 New
45,353 $3.74 Million
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $1.52 Million - $1.69 Million
-20,578 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $705,145 - $815,647
10,534 Added 104.88%
20,578 $1.77 Million
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $1,428 - $1,613
-22 Reduced 0.22%
10,044 $759,000
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $409,247 - $489,248
-5,814 Reduced 36.61%
10,066 $814,000
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $436,728 - $468,790
6,038 Added 61.35%
15,880 $1.28 Million
Q4 2017

Feb 13, 2018

SELL
$72.33 - $77.64 $403,312 - $432,920
-5,576 Reduced 36.17%
9,842 $792,000
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $1.14 Million - $1.19 Million
15,418
15,418 $1.24 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.